English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Merck
Carol Ostrow
| May 16, 2018
FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns
| Jan 17, 2018
FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow
| Jan 7, 2018
Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow
| Oct 15, 2017
Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow
| Oct 1, 2017
Merck to host meeting on third-quarter performance
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Robert Hadley
| Jun 16, 2017
Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Tabitha Fleming
| Jun 2, 2017
Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Trending
+
Pharmaceuticals
Patient Daily
| Feb 19, 2025
American Lung Association hosts Fight For Air Climb in Los Angeles
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
South Florida firefighter aims to defeat lung disease through annual stair climb
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
Expert tips for managing springtime allergies effectively
+
Regulatory
Patient Daily
| Feb 14, 2025
Spokesperson for Patients Come First: 340B program is ‘one of the most blatant abuses of a governmental program’
1
2
»
Last »
